Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
AbbVie (United States) · Fate Therapeutics (United States) · +7 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
843
total citations
- FWCI
- 26.69
- Percentile
- 100%
- References
- 23
Citations per year
Authors
39Topics & keywords
Topics
Keywords
- Lineage (genetic)
- Computational biology
- Drug discovery
- Chemistry
- Biology
- Genetics
- Bioinformatics
- Gene
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.